Agilent Technologies, Inc.
Agilent Technologies, Inc. (A) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
a · pe ratio · data through Oct 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Agilent Technologies, Inc. (A) measures how much investors pay for each dollar of the company's trailing earnings. A's current PE ratio of 26.56x is calculated by dividing its stock price of $132.69 by its TTM earnings per share of $5.00. −16.0% discount vs 5Y avg 31.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-10-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%24.5x
MedianQ3 · 75%65.8x
Max
At 26.56x, A's current P/E is within its average historical range over the past 19 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Agilent Technologies, Inc.You A | $37.5B | 26.56x | -15.9% | $5.00 |
 Alcon Inc. ALC | $32.2B | 39.80x | +26.0% | $1.98 |
 Becton, Dickinson and Company BDX | $54.3B | 25.13x | -20.4% | $5.85 |
 Cardinal Health, Inc. CAH | $47.9B | 25.94x | -17.9% | $6.48 |
 Edwards Lifesciences Corporation EW | $49.4B | 46.44x | +47.0% | $1.84 |
 Haleon plc HLN | $39.5B | 20.62x | -34.7% | $0.36 |
 Insmed Incorporated INSM | $20.4B | N/A | — | -$5.98 |
Industry Average 5 peers with valid PE | — | 31.59x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-10-31Latest FY2025 | 31.79x | $4.60 | +8.4% | |
2024-10-31 FY2024 | 29.32x | $4.44 | +19.6% | |
2023-10-31 FY2023 | 24.51x | $4.22 | -25.7% | |
2022-10-31 FY2022 | 32.99x | $4.19 | -16.4% | |
2021-10-31 FY2021 | 39.46x | $3.98 | -10.1% | |
2020-10-31 FY2020 | 43.87x | $2.33 | +97.6% | |
2019-10-31 FY2019 | 22.21x | $3.41 | -66.3% | |
2018-10-31 FY2018 | 65.82x | $0.98 | +105.5% | |
2017-10-31 FY2017 | 32.03x | $2.12 | +3.7% | |
2016-10-31 FY2016 | 30.88x | $1.41 | -1.5% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Agilent Technologies, Inc. (A) measures how much investors pay for each dollar of the company's trailing earnings. A's current PE ratio of 26.56x is calculated by dividing its stock price of $132.69 by its TTM earnings per share of $5.00.
Frequently asked questions
A pe ratio · 6 questionsA's current PE ratio is 26.56x as of 2026-06-08, based on a stock price of $132.69 and TTM EPS of $5.00. Data sourced from Financial Modeling Prep via A's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Agilent Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08